Targets of chloroacetaldehyde-induced nephrotoxicity

Toxicology in Vitro

Volumn 24, Issue 1, 2010, Pages 99-107

  Knouzy, Burhan ^a,b   Dubourg, Laurence ^a,b,c   Baverel, Gabriel ^a,b,c   Michoudet, Christian ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b INSERM   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Chloroacetaldehyde; Ifosfamide; Kidney; Precision cut slices; Toxicity

Indexed keywords

ADENOSINE TRIPHOSPHATE; CHLOROACETALDEHYDE; GLUTATHIONE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IFOSFAMIDE; LACTIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG METABOLISM; DRUG STRUCTURE; ENZYME INHIBITION; GLUCONEOGENESIS; GLYCOLYSIS; KIDNEY CORTEX; MALE; MITOCHONDRIAL RESPIRATION; NEPHROTOXICITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; RAT;

RATTUS;

EID: 72149116194     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.08.026     Document Type: Article

References (35)

1. Basaran M., Bavbek E.S., Saglam S., Eralp L., Sakar B., Atalar A.C., Bilgic B., Ozger H., and Onat H. A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas. Oncology 72 (2007) 255-260
2. Baverel G., and Lund P. A role for bicarbonate in the regulation of mammalian glutamine metabolism. Biochemical Journal 184 (1979) 599-606
3. Baverel G., Bonnard M., D'Armagnac de Castanet E., and Pellet M. Lactate and pyruvate metabolism in isolated renal tubules of normal dogs. Kidney International 14 (1978) 567-575
4. Benesic A., Schwerdt G., Freudinger R., Mildenberger S., Groezinger F., Wollny B., Kirchhoff A., and Gekle M. Chloroacetaldehyde as a sulfhydryl reagent: the role of critical thiol groups in ifosfamide nephropathy. Kidney and Blood Pressure Research 29 (2006) 280-293
5. Bergmeyer H.U., and Bernt E. Lactate dehydrogenase. UV-assay with pyruvate and NADH. In: Bergmeyer H.U. (Ed). Methods of Enzymatic Analysis (1974), Academic Press, New York 574-579
6. Bruggemann S.K., Kisro J., and Wagner T. Ifosfamide cytotoxicity on human tumor and renal cells: role of chloroacetaldehyde in comparison to 4-hydroxyifosfamide. Cancer Research 57 (1997) 2676-2680
7. Bruggemann S.K., Radike K., Braasch K., Hinrichs J., Kisro J., Hagenah W., Peters S.O., and Wagner T. Chloroacetaldehyde: mode of antitumor action of the ifosfamide metabolite. Cancer Chemotherapy and Pharmacology 57 (2006) 349-356
8. Carli M., Passone E., Perilongo G., and Bisogno G. Ifosfamide in pediatric solid tumors. Oncology 65 Suppl. 2 (2003) 99-104
9. Clottes E., and Burchell A. Three thiol groups are important for the activity of the liver microsomal glucose-6-phosphatase system. Unusual behavior of one thiol located in the glucose-6-phosphate translocase. Journal of Biological Chemistry 273 (1998) 19391-19397
10. Dubourg L., Michoudet C., Cochat P., and Baverel G. Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide. Journal of American Society of Nephrology 12 (2001) 1615-1623
11. Ellman G.L. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 82 (1959) 70-77
12. Goren M.P., Wright R.K., Pratt C.B., and Pell F.E. Dechloroethylation of ifosfamide and neurotoxicity. Lancet 2 (1986) 1219-1220
13. Griffith O.W. Glutathione and glutathione disulfide. In: Bergmeyer H.U., Bergmeyer J., and Grassl M. (Eds). Methods of Enzymatic Analysis vol. VIII (1985), VCH Verlagsgesellschaft, Weinheim 521-529
14. Guder W.G., and Ross B.D. Enzyme distribution along the nephron. Kidney International 26 (1984) 101-111
15. Lamprecht W., and Trautschold I. ATP: determination with hexokinase and glucose-6-phosphate dehydrogenase. In: Bergmeyer H.U. (Ed). Methods of Enzymatic Analysis (1974), Academic Press, New York 2101-2110
16. Latzko E., and Gibbs M. Alkaline C1-fructose-1,6-disphosphatase. In: Bergmeyer H.U., and Gawehn K. (Eds). Methods of Enzymatic Analysis (1974), Verlag Chemie, Weinheim 881-884
17. Lewis C.T., Seyer J.M., and Carlson G.M. Cysteine 288: an essential hyperreactive thiol of cytosolic phosphoenolpyruvate carboxykinase (GTP). Journal of Biological Chemistry 264 (1989) 27-33
18. Lind M.J., McGown A.T., Hadfield J.A., Thatcher N., Crowther D., and Fox B.W. The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo. Biochemical Pharmacology 38 (1989) 1835-1840
19. Liu F., and Fromm H.J. Relationship between thiol group modification and the binding site for fructose 2,6-bisphosphate on rabbit liver fructose-1,6-bisphosphatase. Journal of Biological Chemistry 263 (1988) 10035-10039
20. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
21. Madsen K.M., and Tisher C.C. Structural-functional relationships along the distal nephron. American Journal of Physiology 250 (1986) F1-F15
22. Nissim I., Horyn O., Daikhin Y., Luhovyy B., Phillips P.C., and Yudkoff M. Ifosfamide-induced nephrotoxicity: mechanism and prevention. Cancer Research 66 (2006) 7824-7831
23. Passonneau J.V., and Lowry O.H. Enzymatic analysis: a practical guide (1993), Human Press, Totowa, NJ p. 229
24. Pelicano H., Martin D.S., Xu R.H., and Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 25 (2006) 4633-4646
25. Pendyala L., Creaven P.J., Schwartz G., Meropol N.J., Bolanowska-Higdon W., Zdanowicz J., Murphy M., and Perez R. Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathione. Clinical Cancer Research 6 (2000) 1314-1321
26. Pullar J.M., Winterbourn C.C., and Vissers M.C. Loss of GSH and thiol enzymes in endothelial cells exposed to sublethal concentrations of hypochlorous acid. American Journal of Physiology 277 (1999) H1505-H1512
27. Sakai A., Shimizu H., Kono K., and Furuya E. Monochloroacetic acid inhibits liver gluconeogenesis by inactivating glyceraldehyde-3-phosphate dehydrogenase. Chemical Research in Toxicology 18 (2005) 277-282
28. Schwerdt G., Gordjani N., Benesic A., Freudinger R., Wollny B., Kirchhoff A., and Gekle M. Chloroacetaldehyde- and acrolein-induced death of human proximal tubule cells. Pediatric Nephrology 21 (2006) 60-67
29. Springate J.E. Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo. Journal of Applied Toxicology 17 (1997) 75-79
30. Springate J., and Taub M. Ifosfamide toxicity in cultured proximal renal tubule cells. Pediatric Nephrology 22 (2007) 358-365
31. Trentham D.R. Aspects of the chemistry of d-glyceraldehyde 3-phosphate dehydrogenase. Biochemical Journal 109 (1968) 603-612
32. Verma S., Younus J., Stys-Norman D., Haynes A.E., and Blackstein M. Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline. Current Oncology 14 (2007) 144-148
33. 13C NMR study. Biochemical Journal 387 (2005) 825-834
34. Wagner T. Ifosfamide clinical pharmacokinetics. Clinical Pharmacokinetics 26 (1994) 439-456
35. Zhang J., Tian Q., Yung Chan S., Chuen Li S., Zhou S., Duan W., and Zhu Y.Z. Metabolism and transport of oxazaphosphorines and the clinical implications. Drug Metabolism Reviews 37 (2005) 611-703